Here's Why Inovio Pharmaceuticals Inc. Fell 21.3% in November
Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO), a biopharmaceutical company developing vaccines, fell 21.3% in November according to data from S&P Global Market Intelligence. Despite reporting some important pipeline progress investors weren't pleased with the company's widening losses.
Inovio Pharmaceuticals Inc.'s third-quarter loss grew 64% to $34.1 million from $20.8 million last year. Without product sales to smooth out the bumps, Inovio's top line is prone to exceptional lumpiness from one quarter to the next as it recognizes various one-time cash infusions from collaboration partners.
Image source: Getty Images.
Source: Fool.com
Inovio Pharma Aktie
0,53 €
-2,24 %
Die Community ist uneins: 3 Buy- gegen 2 Sell-Einschätzungen bei Inovio Pharma.
Die Community prognostiziert für Inovio Pharma ein Kursziel von 18 €, was den aktuellen Kurs von 0.53 € weit übertrifft.
